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Introduction
Acinetobacter baumannii is a Gram-negative coccobacillus that has emerged as a serious healthcare-associated pathogen in recent years. Acinetobacter baumannii infection may result in pneumonia, bloodstream infection, urinary tract infection, meningitis and wound infection as well as other manifestations of infection [1] .
Acinetobacter baumannii has a high propensity to cause nosocomial outbreaks, possibly due to its persistence in the hospital environment and its remarkable ability to acquire drug resistance. Several studies indicate significantly increased resistance rates in epidemic A. baumannii strains compared with sporadic strains [1] .
To distinguish outbreak strains from epidemiologically unrelated A. baumannii strains, typing methods such as pulsed-field gel electrophoresis (PFGE), repetitive sequence-based PCR (rep-PCR) and multilocus sequence typing (MLST) are employed [1] . PFGE and rep-PCR have been demonstrated to be more discriminatory than MLST, which is routinely used to put epidemiological information in a global context [2] .
Whilst outbreaks of A. baumannii have been reported in many regions worldwide, including Europe, North America, Latin America, Australia, Asia, the Middle East and South Africa [1] , few data are available for East African A. baumannii isolates. In the current study, antibiotic susceptibility testing, MLST, rep-PCR and PFGE were performed for 25 A. baumannii strains isolated at Aga Khan University Hospital, Nairobi (AKUH, N), Kenya.
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Materials and methods

Collection and identification of Acinetobacter baumannii isolates
The 25 non-repetitive A. baumannii isolates investigated in this study were cultivated at the Division of Microbiology of AKUH, N from the following specimen types: 9 A. baumannii isolates were derived from tracheal aspirates, 5 isolates were from pus swabs, 3 were from nasal swabs, 2 isolates each were from sputum, cerebrospinal fluid (CSF) and urine, and 1 isolate each was derived from blood and unspecified tissue. The two CSF isolates and the tissue sample isolate were considered clinically significant and the patients were specifically treated with colistin. Both CSF samples came from patients with ventricular shunts. All isolates were collected from September 2010 to September 2011. Although a previous outbreak of multiresistant Acinetobacter in the intensive care unit (ICU) [3] had been stopped with highly stringent infection control measures, multidrug-resistant Acinetobacter continued to be isolated from patients admitted to the hospital. Fourteen of the patients had a history of prior admission to the hospital, whilst eight had a history of admission to various other hospitals in Nairobi. Thirteen of the patients were in the ICU at the time of specimen collection. However, their hospital stay was at different time periods.
Identification of the isolates as A. baumannii was reconfirmed by 16S rDNA sequencing in addition to PCR detection of the bla OXA-51-like oxacillinase [4, 5] . 
Bacterial genotyping
Genomic DNA was extracted using an UltraClean ® Microbial DNA Isolation Kit (MO BIO Laboratories, Carlsbad, CA) as recommended by the manufacturer and was used for MLST and rep-PCR analysis. MLST was performed as previously described [7] , making use of the A. baumannii MLST website (http://pubmlst.org/abaumannii/) developed by Keith Jolley and located at the University of Oxford (Oxford, UK). rep-PCR and PFGE typing were used for the increased resolution required for investigation of clonality in outbreak analysis.
rep-PCR typing was performed using a DiversiLab Acinetobacter Kit (bioMérieux, Marcy l'Étoile, France). DiversiLab fingerprints were analysed with DiversiLab software using the Pearson correlation statistical method to determine clonal relationships. Isolates were considered as clonal when the rep-PCR patterns showed ≥95% similarity.
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A c c e p t e d M a n u s c r i p t 6 PFGE was conducted with the restriction enzyme ApaI using a CHEF-DR ® III system (Bio-Rad, Hercules, CA) as previously described [8] .
Resistance gene analysis
Presence of the metallo-β-lactamase gene bla IMP as well as the extended-spectrum β-lactamase (ESBL) gene bla PER-1 and the AmpC β-lactamase gene bla CMY-2 was determined by PCR [9] [10] [11] . The occurrence of carbapenem-hydrolysing class D β-lactamase (oxacillinase) (CHDL) genes, namely bla OXA-51-like , bla OXA-23-like and bla OXA-58-like , was determined by PCR [12] . Detection of insertion sequence ISAba1
upstream of bla OXA-51-like was performed using PCR [13] .
Results and discussion
All isolates were resistant to cefepime, ceftazidime, ticarcillin/clavulanic acid, cefotaxime/clavulanic acid, piperacillin/tazobactam, cefoxitin, ciprofloxacin, gentamicin, nitrofurantoin, fosfomycin trometamol and trimethoprim/sulfamethoxazole. In addition, all isolates except one (AKUH AB008)
showed resistance to meropenem and imipenem. In addition to being susceptible to meropenem and imipenem, isolate AKUH AB008 was also susceptible to amikacin, as were three other isolates. Resistance profiles of meropenem, imipenem and amikacin are illustrated in Fig. 1 .
These investigations showed that three clones of A. baumannii were found within this Kenyan institution. The 25 isolates investigated in this study grouped into three different sequence types (STs) belonging to three different clonal complexes (CCs).
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The most prevalent sequence type was ST110 (17 isolates), followed by ST92 (5 isolates) and ST109 (3 isolates). Worldwide, ST92 and the associated CC92, also known as European clone 2 or worldwide clonal lineage 2, represent the most widespread sequence type(s). ST109 is part of clonal cluster CC1, which is also found worldwide (http://pubmlst.org/abaumannii/).
In this study, the strains of each sequence type shared similar PFGE and rep-PCR profiles. It is worth noting that all of the ST110 isolates were resistant to all of the antibiotics investigated, whilst two isolates of ST92 and two isolates of ST109 were susceptible to amikacin; one of the amikacin-susceptible ST109 isolates was also susceptible to meropenem and imipenem. Isolates of the same sequence type clustered together when analysed by the DiversiLab rep-PCR typing method and PFGE (Fig. 1) . A c c e p t e d M a n u s c r i p t 8 antibiotics investigated, invariably producing OXA-23, antibiotic susceptibility and resistance mechanisms of ST110 were less uniform in other settings [14, 15] .
Whilst in the current study bla OXA-23 was the major carbapenem resistance mechanism detected, a previous report from AKUH, N has shown the antibiotic resistance gene structure ISAba1-bla OXA-23 to be the main mechanism of carbapenemase resistance among 10 Kenyan A. baumannii isolates [3] . In the current study, two strains of ST109 A. baumannii harboured the ISAba1-bla OXA-51-like element. However, the carbapenemase-producing genes bla IMP and bla OXA-58 as well as the ESBL bla PER-1 and AmpC-producing gene bla CMY-2 were not detected.
Thus, the molecular epidemiology of carbapenem-resistant A. baumannii isolates from a single hospital in Kenya reveals the presence of organisms associated with infection elsewhere in the world. The time course of the outbreaks is illustrated in Fig. 2 . It is noteworthy that the first isolate of each sequence type was in a patient transferred from another hospital. Unfortunately, as has occurred elsewhere in the world, introduction of strains from other hospitals and person-to-person spread of hospital-adapted strains of A. baumannii appears to be occurring in Kenyan healthcare facilities.
